Revenue guidance with specifics won't happen Churb

Revenue guidance with specifics won't happen Churbz. If it is being sold, it would not make sense. Why would AMBS throw a number out there if they are in the middle of negotiating? It does not make biz sense. The potential buyer will value Lympro for Alzheimer's, CTE, TBI, NuroPro etc and make an offer. I think they are being quiet because they are either in negotiations or it's done pending a few strategic moves and the eventual owner will do the communicating. AMBS is giving the impression they can launch on their own through ICON, which they can and will. This will increase the value of the asset and forces bidders to keep upping their bid - because as every day passes it will get more and more valuable.

JNap low balled it because he doesn't have enough info to forecast it.